| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM29
|
ADAM metallopeptidase domain 29
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADPGK
|
ADP-dependent glucokinase
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK2
|
adrenergic, beta, receptor kinase 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGR2
|
anterior gradient 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALYREF
|
Aly/REF export factor
|
|
AMH
|
anti-Mullerian hormone
|
|
AMY1A
|
amylase, alpha 1A (salivary)
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANXA1
|
annexin A1
|
|
ANXA5
|
annexin A5
|
|
AOC1
|
amine oxidase, copper containing 1
|
|
APC
|
adenomatous polyposis coli
|
|
APLN
|
apelin
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APOL1
|
apolipoprotein L, 1
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AR
|
androgen receptor
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ATG5
|
autophagy related 5
|
|
ATG9A
|
autophagy related 9A
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP6V1C1
|
ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AXIN1
|
axin 1
|
|
AXIN2
|
axin 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BATF2
|
basic leucine zipper transcription factor, ATF-like 2
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCL9
|
B-cell CLL/lymphoma 9
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEX1
|
brain expressed, X-linked 1
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHLHE41
|
basic helix-loop-helix family, member e41
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BPIFA2
|
BPI fold containing family A, member 2
|
|
BPIFB1
|
BPI fold containing family B, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
CA1
|
carbonic anhydrase I
|
|
CA12
|
carbonic anhydrase XII
|
|
CA2
|
carbonic anhydrase II
|
|
CA9
|
carbonic anhydrase IX
|
|
CALML3
|
calmodulin-like 3
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPG
|
capping protein (actin filament), gelsolin-like
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNL1
|
cyclin L1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCT6A
|
chaperonin containing TCP1, subunit 6A (zeta 1)
|
|
CD109
|
CD109 molecule
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD24
|
CD24 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD5
|
CD5 molecule
|
|
CD80
|
CD80 molecule
|
|
CD82
|
CD82 molecule
|
|
CD9
|
CD9 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC42
|
cell division cycle 42
|
|
CDC6
|
cell division cycle 6
|
|
CDC7
|
cell division cycle 7
|
|
CDC73
|
cell division cycle 73
|
|
CDCA2
|
cell division cycle associated 2
|
|
CDCA3
|
cell division cycle associated 3
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDIPT
|
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CES1
|
carboxylesterase 1
|
|
CES2
|
carboxylesterase 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CLDN1
|
claudin 1
|
|
CLDN7
|
claudin 7
|
|
CLOCK
|
clock circadian regulator
|
|
CNTN1
|
contactin 1
|
|
COL16A1
|
collagen, type XVI, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CSRNP1
|
cysteine-serine-rich nuclear protein 1
|
|
CST3
|
cystatin C
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTGF
|
connective tissue growth factor
|
|
CTHRC1
|
collagen triple helix repeat containing 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSB
|
cathepsin B
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTTN
|
cortactin
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYB561
|
cytochrome b561
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCN
|
decorin
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEC1
|
deleted in esophageal cancer 1
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFA4
|
defensin, alpha 4, corticostatin
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103A
|
defensin, beta 103A
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEPDC1B
|
DEP domain containing 1B
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNASE1L1
|
deoxyribonuclease I-like 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPAGT1
|
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase)
|
|
DPT
|
dermatopontin
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DSC3
|
desmocollin 3
|
|
DSG2
|
desmoglein 2
|
|
DSG3
|
desmoglein 3
|
|
DSPP
|
dentin sialophosphoprotein
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
EMP1
|
epithelial membrane protein 1
|
|
ENDOG
|
endonuclease G
|
|
ENG
|
endoglin
|
|
ENO1
|
enolase 1, (alpha)
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
EREG
|
epiregulin
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV5
|
ets variant 5
|
|
EXO1
|
exonuclease 1
|
|
EXOC4
|
exocyst complex component 4
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAM168A
|
family with sequence similarity 168, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FDCSP
|
follicular dendritic cell secreted protein
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLG
|
filaggrin
|
|
FLOT1
|
flotillin 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXE1
|
forkhead box E1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FPGS
|
folylpolyglutamate synthase
|
|
FRA11F
|
fragile site, aphidicolin type, common, fra(11)(q14.2)
|
|
FSCN2
|
fascin actin-bundling protein 2, retinal
|
|
FST
|
follistatin
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GAS6
|
growth arrest-specific 6
|
|
GAST
|
gastrin
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCG
|
glucagon
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GEMIN2
|
gem (nuclear organelle) associated protein 2
|
|
GGCX
|
gamma-glutamyl carboxylase
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GIT1
|
G protein-coupled receptor kinase interacting ArfGAP 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLCCI1
|
glucocorticoid induced 1
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNAT1
|
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GOLPH3
|
golgi phosphoprotein 3 (coat-protein)
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPR1
|
G protein-coupled receptor 1
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS2
|
hyaluronan synthase 2
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HECA
|
headcase homolog (Drosophila)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXA1
|
homeobox A1
|
|
HOXA10
|
homeobox A10
|
|
HOXA7
|
homeobox A7
|
|
HOXA9
|
homeobox A9
|
|
HOXB4
|
homeobox B4
|
|
HOXB5
|
homeobox B5
|
|
HOXB7
|
homeobox B7
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HTN3
|
histatin 3
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL25
|
interleukin 25
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ILK
|
integrin-linked kinase
|
|
ING1
|
inhibitor of growth family, member 1
|
|
ING5
|
inhibitor of growth family, member 5
|
|
INHBA
|
inhibin, beta A
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB6
|
integrin, beta 6
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KIAA1524
|
KIAA1524
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF13
|
Kruppel-like factor 13
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK13
|
kallikrein-related peptidase 13
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT10
|
keratin 10, type I
|
|
KRT13
|
keratin 13, type I
|
|
KRT14
|
keratin 14, type I
|
|
KRT15
|
keratin 15, type I
|
|
KRT17
|
keratin 17, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT2
|
keratin 2, type II
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT8
|
keratin 8, type II
|
|
LAMA1
|
laminin, alpha 1
|
|
LAMC2
|
laminin, gamma 2
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCN2
|
lipocalin 2
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDLR
|
low density lipoprotein receptor
|
|
LDOC1
|
leucine zipper, down-regulated in cancer 1
|
|
LEKR1
|
leucine, glutamate and lysine rich 1
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LOX
|
lysyl oxidase
|
|
LOXL4
|
lysyl oxidase-like 4
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
LPL
|
lipoprotein lipase
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
|
LTA
|
lymphotoxin alpha
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LTF
|
lactotransferrin
|
|
LY96
|
lymphocyte antigen 96
|
|
LZTS1
|
leucine zipper, putative tumor suppressor 1
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA12
|
melanoma antigen family A12
|
|
MAGEA2
|
melanoma antigen family A2
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGEA5
|
melanoma antigen family A5
|
|
MAGEA6
|
melanoma antigen family A6
|
|
MAGEB2
|
melanoma antigen family B2
|
|
MAGED4B
|
melanoma antigen family D4B
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM5
|
minichromosome maintenance complex component 5
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MCPH1
|
microcephalin 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIA
|
melanoma inhibitory activity
|
|
MIA2
|
melanoma inhibitory activity 2
|
|
MIA3
|
melanoma inhibitory activity family, member 3
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR125A
|
microRNA 125a
|
|
MIR137
|
microRNA 137
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR186
|
microRNA 186
|
|
MIR191
|
microRNA 191
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR203A
|
microRNA 203a
|
|
MIR205
|
microRNA 205
|
|
MIR21
|
microRNA 21
|
|
MIR211
|
microRNA 211
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR27A
|
microRNA 27a
|
|
MIR27B
|
microRNA 27b
|
|
MIR29A
|
microRNA 29a
|
|
MIR31
|
microRNA 31
|
|
MIR3651
|
microRNA 3651
|
|
MIR491
|
microRNA 491
|
|
MIR494
|
microRNA 494
|
|
MIR596
|
microRNA 596
|
|
MIR99A
|
microRNA 99a
|
|
MIRLET7B
|
microRNA let-7b
|
|
MIRLET7D
|
microRNA let-7d
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP20
|
matrix metallopeptidase 20
|
|
MMP28
|
matrix metallopeptidase 28
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSN
|
moesin
|
|
MSX1
|
msh homeobox 1
|
|
MT1F
|
metallothionein 1F
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTUS1
|
microtubule associated tumor suppressor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC7
|
mucin 7, secreted
|
|
MVP
|
major vault protein
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli)
|
|
NEIL2
|
nei endonuclease VIII-like 2 (E. coli)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NID2
|
nidogen 2 (osteonidogen)
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLK
|
nemo-like kinase
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMT1
|
N-myristoyltransferase 1
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCB2
|
nucleobindin 2
|
|
NUMB
|
numb homolog (Drosophila)
|
|
OAZ1
|
ornithine decarboxylase antizyme 1
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OFD1
|
oral-facial-digital syndrome 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
ORAOV1
|
oral cancer overexpressed 1
|
|
ORM1
|
orosomucoid 1
|
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDPN
|
podoplanin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER1
|
period circadian clock 1
|
|
PER2
|
period circadian clock 2
|
|
PFN2
|
profilin 2
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
PIDD1
|
p53-induced death domain protein 1
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PITX1
|
paired-like homeodomain 1
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLG
|
plasminogen
|
|
PLK1
|
polo-like kinase 1
|
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
|
PODXL
|
podocalyxin-like
|
|
PON1
|
paraoxonase 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPFIA1
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROM1
|
prominin 1
|
|
PROS1
|
protein S (alpha)
|
|
PROX1
|
prospero homeobox 1
|
|
PRRX1
|
paired related homeobox 1
|
|
PRTFDC1
|
phosphoribosyl transferase domain containing 1
|
|
PSEN1
|
presenilin 1
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PVR
|
poliovirus receptor
|
|
PXN
|
paxillin
|
|
PYY
|
peptide YY
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RAB3D
|
RAB3D, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2
|
|
RASSF4
|
Ras association (RalGDS/AF-6) domain family member 4
|
|
RB1
|
retinoblastoma 1
|
|
RBMX
|
RNA binding motif protein, X-linked
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RHOA
|
ras homolog family member A
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RPS6
|
ribosomal protein S6
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
RSF1
|
remodeling and spacing factor 1
|
|
S100A14
|
S100 calcium binding protein A14
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A7
|
S100 calcium binding protein A7
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SDC1
|
syndecan 1
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SENP5
|
SUMO1/sentrin specific peptidase 5
|
|
SEPT1
|
septin 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SF3B3
|
splicing factor 3b, subunit 3, 130kDa
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIRT3
|
sirtuin 3
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC36A1
|
solute carrier family 36 (proton/amino acid symporter), member 1
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD6
|
SMAD family member 6
|
|
SMAD7
|
SMAD family member 7
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORD
|
sorbitol dehydrogenase
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR1B
|
small proline-rich protein 1B
|
|
SPRR3
|
small proline-rich protein 3
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STATH
|
statherin
|
|
STMN1
|
stathmin 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYK
|
spleen tyrosine kinase
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TAS1R1
|
taste receptor, type 1, member 1
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
|
TBC1D4
|
TBC1 domain family, member 4
|
|
TBX21
|
T-box 21
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TF
|
transferrin
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFRC
|
transferrin receptor
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
TGM2
|
transglutaminase 2
|
|
TGM3
|
transglutaminase 3
|
|
THBS1
|
thrombospondin 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TKTL1
|
transketolase-like 1
|
|
TLN1
|
talin 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM97
|
transmembrane protein 97
|
|
TMPRSS11A
|
transmembrane protease, serine 11A
|
|
TMPRSS11B
|
transmembrane protease, serine 11B
|
|
TMSB10
|
thymosin beta 10
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOP3A
|
topoisomerase (DNA) III alpha
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPD52L2
|
tumor protein D52-like 2
|
|
TPP2
|
tripeptidyl peptidase II
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSPO
|
translocator protein (18kDa)
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXN
|
thioredoxin
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UPP1
|
uridine phosphorylase 1
|
|
USP22
|
ubiquitin specific peptidase 22
|
|
VANGL1
|
VANGL planar cell polarity protein 1
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VWF
|
von Willebrand factor
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWP1
|
WW domain containing E3 ubiquitin protein ligase 1
|
|
XAF1
|
XIAP associated factor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPNPEP1
|
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
YAP1
|
Yes-associated protein 1
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZIC2
|
Zic family member 2
|
|
ZNF510
|
zinc finger protein 510
|
|
ZYX
|
zyxin
|
